Skip to main content

Table 4 VAS scores at baseline and during the 6-month follow-up

From: Single-dose botulinum toxin type a compared with repeated-dose for treatment of trigeminal neuralgia: a pilot study

Time

Dose group

VAS

P

0w

Single

7.99 ± 1.60

0.441

Repeated

8.27 ± 1.69

 

1w

Single

4.40 ± 2.21

0.089

Repeated

5.45 ± 3.08

 

1mo

Single

2.54 ± 2.37

0.977

Repeated

2.52 ± 2.72

 

2mo

Single

1.66 ± 2.11

0.374

Repeated

2.15 ± 2.69

 

3mo

Single

1.59 ± 2.17

0.198

Repeated

2.36 ± 3.01

 

4mo

Single

2.02 ± 2.53

0.084

Repeated

3.23 ± 3.49

 

5mo

Single

2.42 ± 2.84

0.150

Repeated

3.48 ± 3.58

 

6mo

Single

3.02 ± 3.29

0.095

Repeated

4.32 ± 3.61

 
  1. w week, mo month
  2. Single dose, n = 44; repeated dose, n = 37
Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us